Translational Development Acquisition Corp. (TDAC) is a publicly traded company in the Financial Services — Shell Companies industry listed on NASDAQ. This overview shows the latest price, key valuation ratios, profitability metrics and financial-health indicators used by fundamental investors.
Translational Development Acquisition Corp., founded in 2022 and headquartered in New York, New York, currently conducts no significant business operations. Its primary goal is to complete a business combination, such as a merger, amalgamation, share exchange, asset acquisition, share purchase, or reorganization, with one or more companies.
Analysis Summary
Trailing-twelve-month margins: gross margin 0.0%, operating margin 0.0%, net margin 0.0%.
At the current price of $10.87, TDAC trades at a P/E of 42.22 and an ROE of 3.28%. Market capitalisation stands at $268M.
Balance sheet quality for TDAC: current ratio of 0.1, net debt of $170213. A debt-to-equity below 1.0 typically signals conservative capital structure, while a current ratio above 1.5 indicates comfortable short-term liquidity.
Cash flow quality is below average: free cash flow of -$608387 represents -10% conversion of reported net income. High conversion (above 90%) suggests earnings translate cleanly into cash; lower conversion may indicate working capital tightness or accounting timing differences.
Price
| Price | $10.87 |
| Market Cap | $268M |
| Exchange | NASDAQ |
| Country | US |
Valuation Ratios
| P/E Ratio | 42.22 |
| Price / Book | 1.23 |
| EV / EBITDA | -203.40 |
| Dividend Yield | 0.00% |
Profitability
| Return on Equity | 3.28% |
| Return on Invested Capital | -0.84% |
| Return on Assets | 3.52% |
| Gross Margin | 0.00% |
| Operating Margin | 0.00% |
| Net Margin | 0.00% |
Financial Health
| Debt / Equity | 0.01 |
| Current Ratio | 0.06 |
| Piotroski F-Score | 2 |
| Altman Z-Score | 16.43 |
What to look at in Financial Services
Asset managers, brokers, fintech, exchanges. They are not banks — look at AUM, fees and FCF quality.
- 5y revenue growth — Without growth, there is no long-term value creation
- Operating margin — Good asset managers have >30% margins thanks to scalability
- ROE — Quality financial services have a consistent ROE >15%
- FCF / Net Income — Earnings quality — >90% expected in capital-light businesses
- Debt / Equity — Fintech and brokers with high D/E are time bombs in crises
- P/E vs own 5y — Asset managers have stable multiples in well-known ranges
- Dividend yield + buybacks — These businesses return a lot of capital — look at total yield (div + buybacks)
Peer Comparison
| Symbol | Company | Market Cap | P/E | P/B | ROE |
|---|---|---|---|---|---|
| TDAC | Translational Development Acquisition Corp. | $268M | 42.22 | 1.23 | 3.3% |
| DCRC | Decarbonization Plus Acquisition Corporation III | $2.3T | 4.73 | -19.3% | |
| RTPY | Reinvent Technology Partners Y | $11.6B | |||
| SSPK | Silver Spike Acquisition Corp. | $3.4B | 942.00 | 33.41 | 3.5% |
| CCXIW | Churchill Capital Corp XI Warrants | $2.1B |
Price Performance
| 1 month | +0.18% |
| 3 months | +1.12% |
| Year-to-date | +3.62% |
| 1 year | +5.13% |
52-Week Range
| 52-week High | $10.95 |
| 52-week Low | $10.34 |
| Avg Volume (90d) | 90K |
Related companies: CEP · CEPO · FACT · HCMA · MACI · NTWO · SZZL
Explore sector: Financial Services · Shell Companies
More sections of TDAC: Financials · Valuation · Statistics · Estimates · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks